Monoclonal Antibodies Look to a Bright Future Using mAbs as therapeutics could cut preclinical development time by as much as […]

Genomics Sector Has Fired More Than 1,500 Staff Since January 2001 The following is a general compilation of the number

Biotech Not Cratering, Just Deflating To see where the biotech sector is headed tomorrow, it might be helpful for investors

Cuba seeks new drug markets Inside modern towers that are a pride of Fidel Castro, scientists peer through huge microscopes

Time to Let the Air Out If you think biotech stocks are headed for a breakout anytime soon, allow us

FDA rules need tweaking The biotech industry is suffering a mini-crisis of confidence that mirrors the larger shocks that have

deCODED? A new map of the human genome should help both doctors and biologists

Will R&D Make Merck Hot Again? The drug giant gets out of the prescription business and bets it all on

Will R&D Make Merck Hot Again? The drug giant gets out of the prescription business and bets it all on

Cracking the cancer code Whether a tumor invades the lung or breast is beside the point. Its genetic activity will